01 5McCarthy Tétrault
02 15Sumitomo Pharma Canada, Inc.
01 52538265
02 52606510
03 52814828
04 52824077
01 4LURASIDONE HYDROCHLORIDE
02 16Lurasidone Hydrochloride
01 4TABLET
02 16Tablet
01 52021-09-14
02 52024-07-27
03 52026-05-26
04 52031-05-24
Patent Expiration Date : 2021-09-14
Date Granted : 2016-01-26
Brand Name : LATUDA
Patent Number : 2824077
Filing Date : 2001-09-14
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-09-14
Date Granted : 2016-01-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-09-14
Date Granted : 2016-01-26
Brand Name : LATUDA
Patent Number : 2824077
Filing Date : 2001-09-14
Strength per Unit : 80 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-09-14
Date Granted : 2016-01-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-09-14
Date Granted : 2016-01-26
Brand Name : LATUDA
Patent Number : 2824077
Filing Date : 2001-09-14
Strength per Unit : 120 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-09-14
Date Granted : 2016-01-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-09-14
Date Granted : 2016-01-26
Brand Name : LATUDA
Patent Number : 2824077
Filing Date : 2001-09-14
Strength per Unit : 60 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-09-14
Date Granted : 2016-01-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-09-14
Date Granted : 2016-01-26
Brand Name : LATUDA
Patent Number : 2824077
Filing Date : 2001-09-14
Strength per Unit : 20 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-09-14
Date Granted : 2016-01-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-07-27
Date Granted : 2012-10-02
Brand Name : LATUDA
Patent Number : 2538265
Filing Date : 2004-07-27
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-07-27
Date Granted : 2012-10-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-05-26
Date Granted : 2014-07-22
Brand Name : LATUDA
Patent Number : 2606510
Filing Date : 2006-05-26
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-05-26
Date Granted : 2014-07-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-07-27
Date Granted : 2012-10-02
Brand Name : LATUDA
Patent Number : 2538265
Filing Date : 2004-07-27
Strength per Unit : 80 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-07-27
Date Granted : 2012-10-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-05-26
Date Granted : 2014-07-22
Brand Name : LATUDA
Patent Number : 2606510
Filing Date : 2006-05-26
Strength per Unit : 80 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-05-26
Date Granted : 2014-07-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-07-27
Date Granted : 2012-10-02
Brand Name : LATUDA
Patent Number : 2538265
Filing Date : 2004-07-27
Strength per Unit : 120 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-07-27
Date Granted : 2012-10-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
